EBY-100/pYD-1-RBD
N/A
Report date: 2022/01/06 18:08:22
Base Information
Drug NameEBY-100/pYD-1-RBD
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSouthwest Jiaotong University
China Registration ClassN/A
Develop Information
Active CompaniesSouthwest Jiaotong University
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A